Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.47 CNY
2.98 B CNY
10.72 B CNY
218.97 M
About Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A
Sector
Industry
CEO
Jin Ming Huang
Website
Headquarters
Zhangzhou
Founded
1956
ISIN
CNE000001F21
FIGI
BBG000BMTHB7
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicines. It offers drugs in the form of capsules, ointment, syrup, cream, lozenges, granules and tablets. The company was founded in 1956 and is headquartered in Zhangzhou, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
159919
Harvest SZSE SME-CHINEXT 300 Transactional Open-End Index FundWeight
0.28%
Market value
67.38 M
USD
560080
China Universal CSI Traditional Chinese Medicine Exchange Traded Fund UnitsWeight
10.17%
Market value
25.78 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of 600436 is 197.28 CNY — it has increased by 0.62% in the past 24 hours. Watch Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stocks are traded under the ticker 600436.
600436 stock has fallen by −0.11% compared to the previous week, the month change is a −2.71% fall, over the last year Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A has showed a −13.10% decrease.
We've gathered analysts' opinions on Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A future price: according to them, 600436 price has a max estimate of 298.00 CNY and a min estimate of 188.00 CNY. Watch 600436 chart and read a more detailed Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stock forecast: see what analysts think of Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A and suggest that you do with its stocks.
600436 reached its all-time high on Jul 21, 2021 with the price of 491.88 CNY, and its all-time low was 2.86 CNY and was reached on Jul 19, 2005. View more price dynamics on 600436 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600436 stock is 1.28% volatile and has beta coefficient of 0.81. Track Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stock price on the chart and check out the list of the most volatile stocks — is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A there?
Today Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A has the market capitalization of 117.86 B, it has decreased by −0.34% over the last week.
Yes, you can track Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A financials in yearly and quarterly reports right on TradingView.
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A is going to release the next earnings report on Oct 18, 2025. Keep track of upcoming events with our Earnings Calendar.
600436 earnings for the last quarter are 0.73 CNY per share, whereas the estimation was 1.27 CNY resulting in a −42.52% surprise. The estimated earnings for the next quarter are 1.53 CNY per share. See more details about Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A earnings.
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A revenue for the last quarter amounts to 2.24 B CNY, despite the estimated figure of 2.67 B CNY. In the next quarter, revenue is expected to reach 2.88 B CNY.
600436 net income for the last quarter is 442.53 M CNY, while the quarter before that showed 999.78 M CNY of net income which accounts for −55.74% change. Track more Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A financial stats to get the full picture.
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A dividend yield was 1.38% in 2024, and payout ratio reached 60.19%. The year before the numbers were 0.96% and 50.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2025, the company has 2.84 K employees. See our rating of the largest employees — is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A EBITDA is 3.16 B CNY, and current EBITDA margin is 32.69%. See more stats in Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A financial statements.
Like other stocks, 600436 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A stock shows the sell signal. See more of Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.